The prevalence and awareness of sleep apnea in patients suffering chronic pain: An assessment using the STOP-Bang sleep apnea questionnaire

Gregory S. Tentindo, Scott M Fishman, Chin-Shang Li, Qinlu Wang, Steven D. Brass

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Some patient subsets are at higher risk of sleep apnea, including patients with chronic pain. However, it is unclear whether patients and their caregivers are aware of the possibly increased risk of sleep apnea in this population. Chronic pain is often treated with opioids which may decrease both the central respiratory drive and the patency of the upper airway, potentially contributing to this sleep disorder. Using a self-reporting questionnaire approach in the chronic pain population, this study surveyed patient and caregiver awareness surrounding the risk of sleep apnea. In addition, we looked at the influence of opioid therapy on the prevalence of sleep apnea. Participants and methods: Consecutive patients presenting to a pain clinic were invited to participate anonymously in a survey that included the STOP-Bang sleep apnea questionnaire, which assesses patients’ knowledge, testing, diagnosis, or treatment of sleep apnea and whether their caregivers had discussed with them their increased risk of sleep apnea and opioid use. Results: Among 305 participating patients, 58.2% (n=173) screened positive for sleep apnea. Among the 202 patients on opioid therapy, 59.2% (116/202) were STOP-Bang positive (score ≥3). However, only 37.5% (n=72/173) of these patients had discussed their risk of sleep apnea with a caregiver and only 30.7% (n=59) underwent testing. Against expectation, opioids did not increase the prevalence of sleep apnea in our study population. Conclusion: Chronic pain patients had a high risk of sleep apnea, regardless of opioid prescription. Most patients were unaware of their increased risk and denied undergoing the necessary testing. Greater attention to screening, testing, and education for sleep apnea needs to be paid in chronic pain patients, especially given the potentially dangerous ramifications of opioid-induced sleep apnea.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalNature and Science of Sleep
Volume10
DOIs
StatePublished - Jan 1 2018

Fingerprint

Sleep Apnea Syndromes
Pain Measurement
Chronic Pain
Opioid Analgesics
Caregivers
Surveys and Questionnaires
Population
Pain Clinics
Prescriptions
Therapeutics

Keywords

  • Narcotics
  • Opioids
  • Sleep apnea
  • STOP-Bang survey

ASJC Scopus subject areas

  • Applied Psychology
  • Behavioral Neuroscience

Cite this

The prevalence and awareness of sleep apnea in patients suffering chronic pain : An assessment using the STOP-Bang sleep apnea questionnaire. / Tentindo, Gregory S.; Fishman, Scott M; Li, Chin-Shang; Wang, Qinlu; Brass, Steven D.

In: Nature and Science of Sleep, Vol. 10, 01.01.2018, p. 217-224.

Research output: Contribution to journalArticle

@article{8fb6b915e02644bd9db27f337c6a5530,
title = "The prevalence and awareness of sleep apnea in patients suffering chronic pain: An assessment using the STOP-Bang sleep apnea questionnaire",
abstract = "Purpose: Some patient subsets are at higher risk of sleep apnea, including patients with chronic pain. However, it is unclear whether patients and their caregivers are aware of the possibly increased risk of sleep apnea in this population. Chronic pain is often treated with opioids which may decrease both the central respiratory drive and the patency of the upper airway, potentially contributing to this sleep disorder. Using a self-reporting questionnaire approach in the chronic pain population, this study surveyed patient and caregiver awareness surrounding the risk of sleep apnea. In addition, we looked at the influence of opioid therapy on the prevalence of sleep apnea. Participants and methods: Consecutive patients presenting to a pain clinic were invited to participate anonymously in a survey that included the STOP-Bang sleep apnea questionnaire, which assesses patients’ knowledge, testing, diagnosis, or treatment of sleep apnea and whether their caregivers had discussed with them their increased risk of sleep apnea and opioid use. Results: Among 305 participating patients, 58.2{\%} (n=173) screened positive for sleep apnea. Among the 202 patients on opioid therapy, 59.2{\%} (116/202) were STOP-Bang positive (score ≥3). However, only 37.5{\%} (n=72/173) of these patients had discussed their risk of sleep apnea with a caregiver and only 30.7{\%} (n=59) underwent testing. Against expectation, opioids did not increase the prevalence of sleep apnea in our study population. Conclusion: Chronic pain patients had a high risk of sleep apnea, regardless of opioid prescription. Most patients were unaware of their increased risk and denied undergoing the necessary testing. Greater attention to screening, testing, and education for sleep apnea needs to be paid in chronic pain patients, especially given the potentially dangerous ramifications of opioid-induced sleep apnea.",
keywords = "Narcotics, Opioids, Sleep apnea, STOP-Bang survey",
author = "Tentindo, {Gregory S.} and Fishman, {Scott M} and Chin-Shang Li and Qinlu Wang and Brass, {Steven D.}",
year = "2018",
month = "1",
day = "1",
doi = "10.2147/NSS.S167658",
language = "English (US)",
volume = "10",
pages = "217--224",
journal = "Nature and Science of Sleep",
issn = "1179-1608",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - The prevalence and awareness of sleep apnea in patients suffering chronic pain

T2 - An assessment using the STOP-Bang sleep apnea questionnaire

AU - Tentindo, Gregory S.

AU - Fishman, Scott M

AU - Li, Chin-Shang

AU - Wang, Qinlu

AU - Brass, Steven D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: Some patient subsets are at higher risk of sleep apnea, including patients with chronic pain. However, it is unclear whether patients and their caregivers are aware of the possibly increased risk of sleep apnea in this population. Chronic pain is often treated with opioids which may decrease both the central respiratory drive and the patency of the upper airway, potentially contributing to this sleep disorder. Using a self-reporting questionnaire approach in the chronic pain population, this study surveyed patient and caregiver awareness surrounding the risk of sleep apnea. In addition, we looked at the influence of opioid therapy on the prevalence of sleep apnea. Participants and methods: Consecutive patients presenting to a pain clinic were invited to participate anonymously in a survey that included the STOP-Bang sleep apnea questionnaire, which assesses patients’ knowledge, testing, diagnosis, or treatment of sleep apnea and whether their caregivers had discussed with them their increased risk of sleep apnea and opioid use. Results: Among 305 participating patients, 58.2% (n=173) screened positive for sleep apnea. Among the 202 patients on opioid therapy, 59.2% (116/202) were STOP-Bang positive (score ≥3). However, only 37.5% (n=72/173) of these patients had discussed their risk of sleep apnea with a caregiver and only 30.7% (n=59) underwent testing. Against expectation, opioids did not increase the prevalence of sleep apnea in our study population. Conclusion: Chronic pain patients had a high risk of sleep apnea, regardless of opioid prescription. Most patients were unaware of their increased risk and denied undergoing the necessary testing. Greater attention to screening, testing, and education for sleep apnea needs to be paid in chronic pain patients, especially given the potentially dangerous ramifications of opioid-induced sleep apnea.

AB - Purpose: Some patient subsets are at higher risk of sleep apnea, including patients with chronic pain. However, it is unclear whether patients and their caregivers are aware of the possibly increased risk of sleep apnea in this population. Chronic pain is often treated with opioids which may decrease both the central respiratory drive and the patency of the upper airway, potentially contributing to this sleep disorder. Using a self-reporting questionnaire approach in the chronic pain population, this study surveyed patient and caregiver awareness surrounding the risk of sleep apnea. In addition, we looked at the influence of opioid therapy on the prevalence of sleep apnea. Participants and methods: Consecutive patients presenting to a pain clinic were invited to participate anonymously in a survey that included the STOP-Bang sleep apnea questionnaire, which assesses patients’ knowledge, testing, diagnosis, or treatment of sleep apnea and whether their caregivers had discussed with them their increased risk of sleep apnea and opioid use. Results: Among 305 participating patients, 58.2% (n=173) screened positive for sleep apnea. Among the 202 patients on opioid therapy, 59.2% (116/202) were STOP-Bang positive (score ≥3). However, only 37.5% (n=72/173) of these patients had discussed their risk of sleep apnea with a caregiver and only 30.7% (n=59) underwent testing. Against expectation, opioids did not increase the prevalence of sleep apnea in our study population. Conclusion: Chronic pain patients had a high risk of sleep apnea, regardless of opioid prescription. Most patients were unaware of their increased risk and denied undergoing the necessary testing. Greater attention to screening, testing, and education for sleep apnea needs to be paid in chronic pain patients, especially given the potentially dangerous ramifications of opioid-induced sleep apnea.

KW - Narcotics

KW - Opioids

KW - Sleep apnea

KW - STOP-Bang survey

UR - http://www.scopus.com/inward/record.url?scp=85057986793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057986793&partnerID=8YFLogxK

U2 - 10.2147/NSS.S167658

DO - 10.2147/NSS.S167658

M3 - Article

AN - SCOPUS:85057986793

VL - 10

SP - 217

EP - 224

JO - Nature and Science of Sleep

JF - Nature and Science of Sleep

SN - 1179-1608

ER -